Please login to the form below

Accession announces investment to support next phase of growth

March 2021: Accession Healthcare Consulting (Accession), a specialist pharma market access consultancy, today announces that it has received private investment from a group of highly experienced healthcare and technology investors to support its continued strong performance and ambitious growth plans.

March 2021: Accession Healthcare Consulting (Accession), a specialist pharma market access consultancy, today announces that it has received private investment from a group of highly experienced healthcare and technology investors to support its continued strong performance and ambitious growth plans.

Founded in 2011 by Elliot and Lindsey Rosen, Accession delivers global value and access services to the world’s largest biopharma companies.  As pioneers in the use of digital technology in market access, Accession’s proprietary digital products are transforming how their clients work, compete in the market and engage with their customers.

Accession was named as “One to Watch” in the 2020 Alantra Pharma Fast 50, an annual ranking of the UK’s fastest-growing privately-owned pharma companies.

The investment will be used to accelerate Accession’s track record and focus on using digital technology to disrupt the status quo in their sector and to supercharge the ongoing international expansion of their core products and services. The investment will also provide the means to build out the associated strategic resources and capabilities with a large-scale planned increase in headcount across the organisation.

Elliot Rosen, Co-founder and Managing Director of Accession, said “This investment marks a major milestone for Accession as we continue to push the boundaries of our work in market access consulting.  I am delighted to be partnering with ambitious and supportive investors to expedite the exciting growth plans we have for the business. I am also delighted for the Accession team, the foundation of our success has always been our commitment to having the brightest talent, and I look forward to seeing their careers fly during this new era for Accession’’.

Lindsey Rosen, Co-founder and Director of Accession, added “We founded Accession with a genuine passion to harness the power of market access to ensure patients gain access to life changing medicines. It’s a passion that has been the beating heart of everything we do. This investment means we can now work on more pharmaceutical breakthroughs, add more value to our clients and ultimately play our part in delivering the best possible outcomes for patients’’

Accession was advised by Tom Cowap and Anthony Harrington, who are members of the Pharma Services team at global mid-market investment bank Alantra.

www.accessionhealth.com

18th March 2021

Share

Tags

Company Details

Accession

01491 577563

Contact Website

Address:
Accession Healthcare Consulting Ltd
Southfield House
24 Greys Road
Henley on Thames
Oxfordshire
RG9 1RY
United Kingdom

Latest content on this profile

Accession announces investment to support next phase of growth
March 2021: Accession Healthcare Consulting (Accession), a specialist pharma market access consultancy, today announces that it has received private investment from a group of highly experienced healthcare and technology investors to support its continued strong performance and ambitious growth plans.
Accession